PANC-1(人胰腺癌细胞)

https://789.bio/ec/uSZP0K
  • https://789.bio/ec/uSZP0K
  • https://789.bio/ec/OOR4VP
  • https://789.bio/ec/pqiqPR
  • https://789.bio/ec/GVWi5G
  • https://789.bio/ec/tSpuPG
  • https://789.bio/ec/taqi1R
  • https://789.bio/ec/aDVSOR

货号: CL-0184

Price: ¥1600 ¥1600

Size:
1×10^6Cells/T25 1×10^6Cells/Vial×2Vials

生长培养基: DMEM[PM150210]+10% FBS[164210]+1% P/S[PB180120]

产品信息

产品名称 PANC-1(人胰腺癌细胞)
别称 Panc-1; PANC.1; Panc 1; PanC1; Panc1; PANC1; Panc-1-P
生长特性 贴壁细胞
细胞形态 上皮细胞样
冻存条件 冻存液:55% 基础培养基+40% FBS+5% DMSO
温度:液氮
培养方案A(默认) 生长培养基:DMEM[PM150210]+10% FBS[164210]+1% P/S[PB180120]
培养条件: 气相:空气,95%;CO₂,5%, 温度:37℃
培养方案B(可选) 生长培养基:
培养条件: 气相:, 温度:37℃
推荐传代比例 1:2-1:4
推荐换液频率 2-3次/周

参考资料(来源文献)

背景描述 这株人胰腺癌细胞株PANC-1源自于胰腺癌导管细胞。PANC-1细胞倍增时间为52小时,G6PD活性处于低泳动性的B型。染色体研究表明,PANC-1细胞模式数目为63,包括3个独特标记的染色体和1个小环状染色体。PANC-1细胞的生长可被1 U/mL的左旋天冬酰胺酶抑制;PANC-1细胞能在软琼脂上生长,亦能在裸鼠上成瘤。
年龄(性别) 56Y Male
组织来源 胰腺;胰管;上皮细胞癌
细胞类型 肿瘤细胞
肿瘤类型 胰腺癌细胞
生物安全等级 BSL-1

STR位点信息

STR鉴定图

  • Identifying endoplasmic reticulum stress-related molecular subtypes and prognostic model for predicting the immune landscape and therapy response in pancreatic cancer(2023)

    作者:Biao Zhang, Xu Chen, Zhizhou Wang, Fangyue Guo, Xiaonan Zhang, Bingqian Huang, Shurong Ma, Shilin Xia, Dong Shang

    期刊:Aging-US

    DOI:10.18632/aging.205094

    影响因子:5.2

    引用产品: CFPAC-1 细胞, PANC-1 细胞

  • Identification of key pharmacological components and targets for Aidi injection in the treatment of pancreatic cancer by UPLC-MS, network pharmacology, and in vivo experiments(2023)

    作者:Wang Haojia, Wu Zhishan, Fan Xiaotian, Wu Chao, Lu Shan, Geng Libo, Stalin Antony, Zhu Yingli, Zhang Fanqin, Huang Jiaqi, Liu Pengyun, Li Huiying, You Leiming, Wu Jiarui

    期刊:Chinese Medicine

    DOI:10.1186/s13020-023-00710-2

    影响因子:4.9

    引用产品: PANC-1 细胞

  • Identification of a chemoresistance-related prognostic gene signature by comprehensive analysis and experimental validation in pancreatic cancer(2023)

    作者:Chen Junliang, Liu Zhihao, Wu Zhiyuan, Li Wenjun, Tan Xiaodong

    期刊:Frontiers in Oncology

    DOI:10.3389/fonc.2023.1132424

    影响因子:4.7

    引用产品: AsPC-1 细胞, CFPAC-1 细胞, PANC-1 细胞, IMDM 培养基, DMEM高糖 培养基, 特级胎牛血清, 青霉素-链霉素溶液 (双抗),100×

  • PANoptosis-related molecular subtype and prognostic model associated with the immune microenvironment and individualized therapy in pancreatic cancer(2023)

    作者:Zhang Biao, Huang Bingqian, Zhang Xiaonan, Li Shuang, Zhu Jingyi, Chen Xu, Song Huiyi, Shang Dong

    期刊:Frontiers in Oncology

    DOI:10.3389/fonc.2023.1217654

    影响因子:4.7

    引用产品: PANC-1 细胞, CFPAC-1 细胞

  • Identification and characterization of interferon-γ signaling-based personalized heterogeneity and therapeutic strategies in patients with pancreatic cancer(2023)

    作者:Chen Xu, Yuan Qihang, Guan Hewen, Shi Xueying, Sun Jiaao, Wu Zhiqiang, Ren Jie, Xia Shilin, Shang Dong

    期刊:Frontiers in Oncology

    DOI:10.3389/fonc.2023.1227606

    影响因子:4.7

    引用产品: BxPC-3 细胞, PANC-1 细胞, CFPAC-1 细胞, MIA PaCa-2 细胞

  • Effects of anoxic prognostic model on immune microenvironment in pancreatic cancer(2023)

    作者:Wu Yangdong, Kou Qingyan, Sun Lin, Hu Xiao

    期刊:Scientific Reports

    DOI:10.1038/s41598-023-36413-9

    影响因子:4.6

    引用产品: PANC-1 细胞

  • Lactobacillus casei combined with Lactobacillus reuteri alleviate pancreatic cancer by inhibiting TLR4 to promote macrophage M1 polarization and regulate gut microbial homeostasis(2023)

    作者:Zhu Zemin, Yi Bo, Tang Zikai, Chen Xun, Li Ming, Xu Tao, Zhao Zhijian, Tang Caixi

    期刊:BMC CANCER

    DOI:10.1186/s12885-023-11557-z

    影响因子:3.8

    引用产品: MIA PaCa-2 细胞, PANC-1 细胞, AsPC-1 细胞, BxPC-3 细胞, THP-1 细胞, DMEM高糖 培养基, RPMI-1640 培养基, 特级胎牛血清, 马血清, 青霉素-链霉素溶液 (双抗),100×, β-巯基乙醇 (55mM),1000×

  • Circadian Genes MBOAT2/CDA/LPCAT2/B4GALT5 in the Metabolic Pathway Serve as New Biomarkers of PACA Prognosis and Immune Infiltration(2023)

    作者:Qingqing Wang, Shuning Zhou, Xinyi Hu, Xianggang Wang, Xue Wu, Ziyou Huai, Yu Gao, Shujing Li

    期刊:Life-Basel

    DOI:10.3390/life13051116

    影响因子:3.2

    引用产品: PANC-1 细胞, DMEM高糖 培养基

  • A prospective prognostic signature for pancreatic adenocarcinoma based on ubiquitination-related mRNA-lncRNA with experimental validation in vitro and vivo(2023)

    作者:Wang Zhizhou, Yuan Qihang, Chen Xu, Luo Fei, Shi Xueying, Guo Fangyue, Ren Jie, Li Shuang, Shang Dong

    期刊:FUNCTIONAL & INTEGRATIVE GENOMICS

    DOI:10.1007/s10142-023-01158-1

    影响因子:2.9

    引用产品: CFPAC-1 细胞, PANC-1 细胞, IMEM

  • Comprehensive pan-cancer analysis of role of GPRASP1, associated with clinical outcomes, immune microenvironment, and immunotherapeutic efficiency in pancreatic cancer(2023)

    作者:Jiaxing Du, Yongsheng Chen, Genglong Liu, Qingxing Zeng, Nan Zhou, Dajun Du

    期刊:PATHOLOGY RESEARCH AND PRACTICE

    DOI:10.1016/j.prp.2023.154374

    影响因子:2.8

    引用产品: PANC-1 细胞, MIA PaCa-2 细胞, BxPC-3 细胞, SW 1990 细胞, AsPC-1 细胞

  • Q1:为什么我看的文献里的细胞培养条件和你们官网的培养条件不一样呢?

    部分细胞是会出现多种培养条件的,我们公司优先选择引种来源的培养条件以及建系者所用培养条件,出现差异的原因是不同实验室在保藏过程中更改了细胞的培养条件,为了避免细胞突然更换培养条件后不适应,建议您优先使用厂家推荐的培养条件培养。

识别码示意图

联系我们

400-999-2100

24小时服务热线

sales@procell.com.cn

销售邮箱

×
微信客服 联系我们 返回顶部
在线咨询